<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="lead">
            <roleset id="lead.01" name="resulted&#x0A;" wordnet="3">
                <roles>
                    <role n="0" descr="factors&#x0A;" />
                    <role n="1" descr="result&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>Disruption of the SNU246 gene in yeast was lethal and could lead to a splicing defect in vivo, indicating that the protein is essential for splicing.</text>
                    <arg n="0">Disruption of the SNU246 gene in yeast</arg>
                    <arg n="1">a splicing defect in vivo, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>In mice, inactivation of the MEF2C gene, which is the first MEF2 isoform expressed during embryonic development, which led to cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5 (Lin et al., 1997, 1998; Bi et al., 1999).</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>In this homologous part of the genes, GPB lacks one exon due to a point mutation at the 5 splicing site of the third intron, which inactivated the 5 cleavage event of splicing and has led to ligation of the second to the fourth exon.</text>
                    <arg n="0">a point mutation at the 5 splicing site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>The splice mutation in 5 end of intron 5 has led to abnormal splice in exon 5 and exon 6 appears to be one of the causes of X-linked recessive adrenoleukodystrophy.</text>
                    <arg n="0">The splice mutation in 5 end of intron 5</arg>
                    <arg n="1">abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>This G:C base pair is also the strongest determinant in the sequence selection experiment which has led to the identification of the BRE (Lagrange et al., 1998).</text>
                    <arg n="0">the sequence selection experiment</arg>
                    <arg n="1">the identification of the BRE</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>This G:C base pair is also the strongest determinant in the sequence selection experiment which led to the identification of the BRE (Lagrange et al., 1998).</text>
                    <arg n="0">the sequence selection experiment</arg>
                    <arg n="1">the identification of the BRE</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>This splice mutation in 5 end of intron 5 might has led to abnormal splice in exon 5 and exon 6 and has brought about unstable and abnormal ALD protein; the lignoceryl CoA ligase could not transport very long chain fatty acids (VLCFA) into peroxisome and could not function normally; consequently, defective beta-oxidation of VLCFA in peroxisome could result in an accumulation of VLCFAS in the central nervous system, adrenal gland and blood.</text>
                    <arg n="0">This splice mutation in 5 end of intron 5</arg>
                    <arg n="1">abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>This was caused by a point mutation (GTC----ATC) at codon 383 which can lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter.</text>
                    <arg n="0">a point mutation (GTC----ATC) at codon 383</arg>
                    <arg n="1">the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter</arg>
                </example>
                <example src="GREC" no="1">
                    <text>Closer examination of the putative signal transduction pathway modulating htrA transcription has led us to the identification of two new genes.</text>
                    <arg n="0">Closer examination of the putative signal transduction pathway modulating htrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>7 missense mutations, 2 mutations can lead to frameshift.</text>
                    <arg n="0">7 missense mutations, 2 mutations</arg>
                    <arg n="1">frameshift</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>7 missense mutations, 2 mutations is able to lead to frameshift (Figure 3A).</text>
                    <arg n="0">7 missense mutations, 2 mutations</arg>
                    <arg n="1">frameshift</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>By direct sequencing of aberrant SSCA conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients. Of these, 10 were novel (This which lead to a substantial diversity of nebulin and nebulette isoforms, and 1 mutation predicted to affect normal splicing).</text>
                    <arg n="0">This</arg>
                    <arg n="1">a substantial diversity of nebulin and nebulette isoforms</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>By direct sequencing of aberrant SSCA conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients. Of these, 10 were novel (This which lead to synergistic activation of the ANF and other MEF2 target promoters, and 1 mutation predicted to affect normal splicing).</text>
                    <arg n="0">This</arg>
                    <arg n="1">synergistic activation of the ANF and other MEF2 target promoters</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>By direct sequencing of aberrant SSCA conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients. Of these, 10 were novel (Transduction of the marA region from a Mar strain that led to loss of OmpF, and 1 mutation predicted to affect normal splicing).</text>
                    <arg n="0">Transduction of the marA region from a Mar strain</arg>
                    <arg n="1">loss of OmpF</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>By direct sequencing of aberrant SSCA conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients. Of these, 10 were novel (phosphorylation of the MuSK NPXY site that led to recruitment of a phosphotyrosine-binding domain-containing protein, and 1 mutation predicted to affect normal splicing).</text>
                    <arg n="0">phosphorylation of the MuSK NPXY site</arg>
                    <arg n="1">recruitment of a phosphotyrosine-binding domain-containing protein</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>By direct sequencing of aberrant SSCA conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients. Of these, 10 were novel (phosphorylation of the MuSK NPXY site which led to recruitment of a phosphotyrosine-binding domain-containing protein, and 1 mutation predicted to affect normal splicing).</text>
                    <arg n="0">phosphorylation of the MuSK NPXY site</arg>
                    <arg n="1">recruitment of a phosphotyrosine-binding domain-containing protein</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Closer examination of the putative signal transduction pathway modulating htrA transcription, in turn, is able to lead to the identification of two new genes independently of the DNA-binding activity of MEF2.</text>
                    <arg n="0">Closer examination of the putative signal transduction pathway modulating htrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Closer examination of the putative signal transduction pathway modulating htrA transcription, in turn, is leading to the identification of two new genes independently of the DNA-binding activity of MEF2.</text>
                    <arg n="0">Closer examination of the putative signal transduction pathway modulating htrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>Cotransfection of GATA-4 with MEF2A, MEF2C or MEF2D led to a synergistic 40-to 50-fold activation of the ANF promoter.</text>
                    <arg n="0">Cotransfection of GATA-4 with MEF2A, MEF2C or MEF2D</arg>
                    <arg n="1">a synergistic 40-to 50-fold activation of the ANF promoter</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>DNA (nCaRE)-ref1 interaction lead to C2+e-mediated transcriptional suppression.</text>
                    <arg n="0">DNA (nCaRE)-ref1 interaction</arg>
                    <arg n="1">C2+e-mediated transcriptional suppression</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>DNA (nCaRE)-ref1 interaction, in turn, leads to C2+e-mediated transcriptional suppression independently of the DNA-binding activity of MEF2.</text>
                    <arg n="0">DNA (nCaRE)-ref1 interaction</arg>
                    <arg n="1">C2+e-mediated transcriptional suppression</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggested that Genetic deficiency of GM2 activator could lead to a neurological disorder.</text>
                    <arg n="0">Genetic deficiency of GM2 activator</arg>
                    <arg n="1">a neurological disorder</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggested that This could lead to synergistic activation of the ANF and other MEF2 target promoters.</text>
                    <arg n="0">This</arg>
                    <arg n="1">synergistic activation of the ANF and other MEF2 target promoters</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggested that This was able to lead to synergistic activation of the ANF and other MEF2 target promoters.</text>
                    <arg n="0">This</arg>
                    <arg n="1">synergistic activation of the ANF and other MEF2 target promoters</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggested that Transduction of the marA region from a Mar strain had led to loss of OmpF.</text>
                    <arg n="0">Transduction of the marA region from a Mar strain</arg>
                    <arg n="1">loss of OmpF</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggested that Transduction of the marA region from a Mar strain was able to lead to loss of OmpF.</text>
                    <arg n="0">Transduction of the marA region from a Mar strain</arg>
                    <arg n="1">loss of OmpF</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggests that the sequence selection experiment leads to the identification of the BRE.</text>
                    <arg n="0">the sequence selection experiment</arg>
                    <arg n="1">the identification of the BRE</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>It has been shown that a point mutation (GTC----ATC) at codon 383, leading to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter.</text>
                    <arg n="0">a point mutation (GTC----ATC) at codon 383</arg>
                    <arg n="1">the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>These data suggest that 7 missense mutations, 2 mutations will lead to frameshift that functions to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">7 missense mutations, 2 mutations</arg>
                    <arg n="1">frameshift</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>These data suggest that Cotransfection of GATA-4 with MEF2A, MEF2C or MEF2D has led to a synergistic 40-to 50-fold activation of the ANF promoter that functions to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">Cotransfection of GATA-4 with MEF2A, MEF2C or MEF2D</arg>
                    <arg n="1">a synergistic 40-to 50-fold activation of the ANF promoter</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>These data suggested that 7 missense mutations, 2 mutations was able to lead to frameshift that functions to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">7 missense mutations, 2 mutations</arg>
                    <arg n="1">frameshift</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>These data suggested that Closer examination of the putative signal transduction pathway modulating htrA transcription led to the identification of two new genes that functions to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">Closer examination of the putative signal transduction pathway modulating htrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>These data suggested that This was able to lead to synergistic activation of the ANF and other MEF2 target promoters that functions to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">This</arg>
                    <arg n="1">synergistic activation of the ANF and other MEF2 target promoters</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>This G:C base pair is also the strongest determinant in Closer examination of the putative signal transduction pathway modulating htrA transcription that leads to the identification of two new genes (Lagrange et al., 1998).</text>
                    <arg n="0">Closer examination of the putative signal transduction pathway modulating htrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>This G:C base pair is also the strongest determinant in Closer examination of the putative signal transduction pathway modulating htrA transcription, which led to the identification of two new genes (Lagrange et al., 1998).</text>
                    <arg n="0">Closer examination of the putative signal transduction pathway modulating htrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>This G:C base pair is also the strongest determinant in DNA (nCaRE)-ref1 interaction which has led to C2+e-mediated transcriptional suppression (Lagrange et al., 1998).</text>
                    <arg n="0">DNA (nCaRE)-ref1 interaction</arg>
                    <arg n="1">C2+e-mediated transcriptional suppression</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>This G:C base pair is also the strongest determinant in This leading to a substantial diversity of nebulin and nebulette isoforms (Lagrange et al., 1998).</text>
                    <arg n="0">This</arg>
                    <arg n="1">a substantial diversity of nebulin and nebulette isoforms</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>This G:C base pair is also the strongest determinant in This that leads to a substantial diversity of nebulin and nebulette isoforms (Lagrange et al., 1998).</text>
                    <arg n="0">This</arg>
                    <arg n="1">a substantial diversity of nebulin and nebulette isoforms</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>This G:C base pair is also the strongest determinant in This that leads to a substantial diversity of nebulin and nebulette isoforms (Lagrange et al., 1998).</text>
                    <arg n="0">This</arg>
                    <arg n="1">a substantial diversity of nebulin and nebulette isoforms</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>This G:C base pair is also the strongest determinant in This that leads to a substantial diversity of nebulin and nebulette isoforms (Lagrange et al., 1998).</text>
                    <arg n="0">This</arg>
                    <arg n="1">a substantial diversity of nebulin and nebulette isoforms</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>This G:C base pair is also the strongest determinant in Transduction of the marA region from a Mar strain which has led to loss of OmpF (Lagrange et al., 1998).</text>
                    <arg n="0">Transduction of the marA region from a Mar strain</arg>
                    <arg n="1">loss of OmpF</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>This can lead to a substantial diversity of nebulin and nebulette isoforms, an atypical form of Tay-Sachs disease (GM2 gangliosidosis variant AB).</text>
                    <arg n="0">This</arg>
                    <arg n="1">a substantial diversity of nebulin and nebulette isoforms</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>This can lead to a substantial diversity of nebulin and nebulette isoforms, an atypical form of Tay-Sachs disease (GM2 gangliosidosis variant AB).</text>
                    <arg n="0">This</arg>
                    <arg n="1">a substantial diversity of nebulin and nebulette isoforms</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>This leads to a substantial diversity of nebulin and nebulette isoforms (Figure 3A).</text>
                    <arg n="0">This</arg>
                    <arg n="1">a substantial diversity of nebulin and nebulette isoforms</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>This was caused by 7 missense mutations, 2 mutations which has led to frameshift.</text>
                    <arg n="0">7 missense mutations, 2 mutations</arg>
                    <arg n="1">frameshift</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>This was caused by Closer examination of the putative signal transduction pathway modulating htrA transcription that leads to the identification of two new genes.</text>
                    <arg n="0">Closer examination of the putative signal transduction pathway modulating htrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>This was caused by Closer examination of the putative signal transduction pathway modulating htrA transcription which has led to the identification of two new genes.</text>
                    <arg n="0">Closer examination of the putative signal transduction pathway modulating htrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>This was caused by Crl stimulates the activity of sigma (S) leading to an increased transcription rate of a subset of genes of the rpoS regulon in stationary phase.</text>
                    <arg n="0">Crl stimulates the activity of sigma (S)</arg>
                    <arg n="1">an increased transcription rate of a subset of genes of the rpoS regulon in stationary phase</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>This was caused by DNA (nCaRE)-ref1 interaction leading to C2+e-mediated transcriptional suppression.</text>
                    <arg n="0">DNA (nCaRE)-ref1 interaction</arg>
                    <arg n="1">C2+e-mediated transcriptional suppression</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>This was caused by This which can lead to synergistic activation of the ANF and other MEF2 target promoters.</text>
                    <arg n="0">This</arg>
                    <arg n="1">synergistic activation of the ANF and other MEF2 target promoters</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>This was caused by This which has led to a substantial diversity of nebulin and nebulette isoforms.</text>
                    <arg n="0">This</arg>
                    <arg n="1">a substantial diversity of nebulin and nebulette isoforms</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>This was caused by phosphorylation of the MuSK NPXY site leading to recruitment of a phosphotyrosine-binding domain-containing protein.</text>
                    <arg n="0">phosphorylation of the MuSK NPXY site</arg>
                    <arg n="1">recruitment of a phosphotyrosine-binding domain-containing protein</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>Transduction of the marA region from a Mar strain, in turn, led to loss of OmpF independently of the DNA-binding activity of MEF2.</text>
                    <arg n="0">Transduction of the marA region from a Mar strain</arg>
                    <arg n="1">loss of OmpF</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>Transduction of the marA region from a Mar strain, in turn, led to loss of OmpF independently of the DNA-binding activity of MEF2.</text>
                    <arg n="0">Transduction of the marA region from a Mar strain</arg>
                    <arg n="1">loss of OmpF</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>a point mutation (GTC----ATC) at codon 383 is leading to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter, an atypical form of Tay-Sachs disease (GM2 gangliosidosis variant AB).</text>
                    <arg n="0">a point mutation (GTC----ATC) at codon 383</arg>
                    <arg n="1">the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>a point mutation (GTC----ATC) at codon 383, but not a wild-type strain, led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter.</text>
                    <arg n="0">a point mutation (GTC----ATC) at codon 383</arg>
                    <arg n="1">the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>phosphorylation of the MuSK NPXY site can lead to recruitment of a phosphotyrosine-binding domain-containing protein.</text>
                    <arg n="0">phosphorylation of the MuSK NPXY site</arg>
                    <arg n="1">recruitment of a phosphotyrosine-binding domain-containing protein</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>the sequence selection experiment leads us to the identification of the BRE.</text>
                    <arg n="0">the sequence selection experiment</arg>
                    <arg n="1">the identification of the BRE</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>the sequence selection experiment, in turn, will lead to the identification of the BRE independently of the DNA-binding activity of MEF2.</text>
                    <arg n="0">the sequence selection experiment</arg>
                    <arg n="1">the identification of the BRE</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>the sequence selection experiment, in turn, will lead to the identification of the BRE independently of the DNA-binding activity of MEF2.</text>
                    <arg n="0">the sequence selection experiment</arg>
                    <arg n="1">the identification of the BRE</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>By direct sequencing of aberrant SSCA conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients. Of these, 10 were novel (a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele that lead to a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein, and 1 mutation predicted to affect normal splicing).</text>
                    <arg n="0">a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele</arg>
                    <arg n="1">a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>By direct sequencing of aberrant SSCA conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients. Of these, 10 were novel (a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele that led to a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein, and 1 mutation predicted to affect normal splicing).</text>
                    <arg n="0">a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele</arg>
                    <arg n="1">a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>By direct sequencing of aberrant SSCA conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients. Of these, 10 were novel (a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele that led to a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein, and 1 mutation predicted to affect normal splicing).</text>
                    <arg n="0">a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele</arg>
                    <arg n="1">a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>By direct sequencing of aberrant SSCA conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients. Of these, 10 were novel (inactivation of the MEF2C gene that lead to cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5, and 1 mutation predicted to affect normal splicing).</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>By direct sequencing of aberrant SSCA conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients. Of these, 10 were novel (the distinct amino termini that lead to the targeting of individual VDAC isoforms to different cellular compartments, and 1 mutation predicted to affect normal splicing).</text>
                    <arg n="0">the distinct amino termini</arg>
                    <arg n="1">the targeting of individual VDAC isoforms to different cellular compartments</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>By direct sequencing of aberrant SSCA conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients. Of these, 10 were novel (two frameshifts and a splice site mutation that led to truncated OA1 proteins; a deletion of a threonine codon at position 290; and four missense mutations, and 1 mutation predicted to affect normal splicing).</text>
                    <arg n="0">two frameshifts and a splice site mutation</arg>
                    <arg n="1">truncated OA1 proteins; a deletion of a threonine codon at position 290; and four missense mutations</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>Disruption of the SNU246 gene in yeast G:C base pair is also the strongest determinant in This leading to a splicing defect in vivo, indicating that the protein is essential for splicing (Lagrange et al., 1998).</text>
                    <arg n="0">Disruption of the SNU246 gene in yeast</arg>
                    <arg n="1">a splicing defect in vivo, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>Disruption of the SNU246 gene in yeast can lead to a splicing defect in vivo, indicating that the protein is essential for splicing (Figure 3A).</text>
                    <arg n="0">Disruption of the SNU246 gene in yeast</arg>
                    <arg n="1">a splicing defect in vivo, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>Disruption of the SNU246 gene in yeast is able to lead to a splicing defect in vivo, indicating that the protein is essential for splicing (Figure 3A).</text>
                    <arg n="0">Disruption of the SNU246 gene in yeast</arg>
                    <arg n="1">a splicing defect in vivo, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>Disruption of the SNU246 gene in yeast leads to a splicing defect in vivo, indicating that the protein is essential for splicing, an atypical form of Tay-Sachs disease (GM2 gangliosidosis variant AB).</text>
                    <arg n="0">Disruption of the SNU246 gene in yeast</arg>
                    <arg n="1">a splicing defect in vivo, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>Disruption of the SNU246 gene in yeast, in turn, is leading to a splicing defect in vivo, indicating that the protein is essential for splicing independently of the DNA-binding activity of MEF2.</text>
                    <arg n="0">Disruption of the SNU246 gene in yeast</arg>
                    <arg n="1">a splicing defect in vivo, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggested that G979A affects a splice consensus site at the end of exon 8, and G1488T in exon 14 led to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S).</text>
                    <arg n="0">G979A affects a splice consensus site at the end of exon 8, and G1488T in exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggested that Growth of Escherichia coli in the presence of nitrate or nitrite could lead to a 45% decrease in expression.</text>
                    <arg n="0">Growth of Escherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% decrease in expression</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggested that Growth of Escherichia coli in the presence of nitrate or nitrite had led to a 45% decrease in expression.</text>
                    <arg n="0">Growth of Escherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% decrease in expression</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggested that The loss of TreR function had led to derepression of treB.</text>
                    <arg n="0">The loss of TreR function</arg>
                    <arg n="1">derepression of treB</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggested that This splice mutation in 5 end of intron 5 could lead to abnormal splice in exon 5 and exon 6.</text>
                    <arg n="0">This splice mutation in 5 end of intron 5</arg>
                    <arg n="1">abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggested that a point mutation at the 5 splicing site of the third intron could lead to ligation of the second to the fourth exon.</text>
                    <arg n="0">a point mutation at the 5 splicing site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggests that The loss of TreR function is able to lead to derepression of treB.</text>
                    <arg n="0">The loss of TreR function</arg>
                    <arg n="1">derepression of treB</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggests that a point mutation at the 5 splicing site of the third intron is able to lead to ligation of the second to the fourth exon.</text>
                    <arg n="0">a point mutation at the 5 splicing site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggests that inactivation of the MEF2C gene leads to cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>Further, experiments with an antisense-ref cDNA expression vector introduced into cultured cells suggests that the distinct amino termini leads to the targeting of individual VDAC isoforms to different cellular compartments.</text>
                    <arg n="0">the distinct amino termini</arg>
                    <arg n="1">the targeting of individual VDAC isoforms to different cellular compartments</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14 can lead to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S), an atypical form of Tay-Sachs disease (GM2 gangliosidosis variant AB).</text>
                    <arg n="0">G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14 was caused by This that leads to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S).</text>
                    <arg n="0">G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14 was caused by This which can lead to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S).</text>
                    <arg n="0">G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14 was caused by This, which leads to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S).</text>
                    <arg n="0">G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14 will lead us to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S).</text>
                    <arg n="0">G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>G979A affects a splice consensus site at the end of exon 8, and G1488T in exon 14 is leading to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S), an atypical form of Tay-Sachs disease (GM2 gangliosidosis variant AB).</text>
                    <arg n="0">G979A affects a splice consensus site at the end of exon 8, and G1488T in exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>G979A affects a splice consensus site at the end of exon 8, and G1488T in exon 14 was caused by This that leads to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S).</text>
                    <arg n="0">G979A affects a splice consensus site at the end of exon 8, and G1488T in exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>G979A affects a splice consensus site at the end of exon 8, and G1488T in exon 14, but not a wild-type strain, led to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S).</text>
                    <arg n="0">G979A affects a splice consensus site at the end of exon 8, and G1488T in exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>Growth of Escherichia coli in the presence of nitrate or nitrite G:C base pair is also the strongest determinant in This which leads to a 45% decrease in expression (Lagrange et al., 1998).</text>
                    <arg n="0">Growth of Escherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% decrease in expression</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>Growth of Escherichia coli in the presence of nitrate or nitrite G:C base pair is also the strongest determinant in This which led to a 45% decrease in expression (Lagrange et al., 1998).</text>
                    <arg n="0">Growth of Escherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% decrease in expression</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>Growth of Escherichia coli in the presence of nitrate or nitrite leads to a 45% decrease in expression, an atypical form of Tay-Sachs disease (GM2 gangliosidosis variant AB).</text>
                    <arg n="0">Growth of Escherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% decrease in expression</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>It has been shown that The loss of TreR function, leading to derepression of treB.</text>
                    <arg n="0">The loss of TreR function</arg>
                    <arg n="1">derepression of treB</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>It has been shown that a point mutation at the 5 splicing site of the third intron, leading to ligation of the second to the fourth exon.</text>
                    <arg n="0">a point mutation at the 5 splicing site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>The loss of TreR function is able to lead to derepression of treB (Figure 3A).</text>
                    <arg n="0">The loss of TreR function</arg>
                    <arg n="1">derepression of treB</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>The loss of TreR function leads to derepression of treB (Figure 3A).</text>
                    <arg n="0">The loss of TreR function</arg>
                    <arg n="1">derepression of treB</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>The loss of TreR function leads us to derepression of treB.</text>
                    <arg n="0">The loss of TreR function</arg>
                    <arg n="1">derepression of treB</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>The loss of TreR function was caused by This that led to derepression of treB.</text>
                    <arg n="0">The loss of TreR function</arg>
                    <arg n="1">derepression of treB</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>The loss of TreR function was caused by This which can lead to derepression of treB.</text>
                    <arg n="0">The loss of TreR function</arg>
                    <arg n="1">derepression of treB</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>The splice mutation in 5 end of intron 5 led to abnormal splice in exon 5 and exon 6 (Figure 3A).</text>
                    <arg n="0">The splice mutation in 5 end of intron 5</arg>
                    <arg n="1">abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>These data suggest that Disruption of the SNU246 gene in yeast has led to a splicing defect in vivo, indicating that the protein is essential for splicing that functions to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">Disruption of the SNU246 gene in yeast</arg>
                    <arg n="1">a splicing defect in vivo, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>These data suggest that Growth of Escherichia coli in the presence of nitrate or nitrite has led to a 45% decrease in expression that functions to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">Growth of Escherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% decrease in expression</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>These data suggested that a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele was able to lead to a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein that functions to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele</arg>
                    <arg n="1">a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>This G:C base pair is also the strongest determinant in Disruption of the SNU246 gene in yeast which has led to a splicing defect in vivo, indicating that the protein is essential for splicing (Lagrange et al., 1998).</text>
                    <arg n="0">Disruption of the SNU246 gene in yeast</arg>
                    <arg n="1">a splicing defect in vivo, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>This G:C base pair is also the strongest determinant in G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14 that leads to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S) (Lagrange et al., 1998).</text>
                    <arg n="0">G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>This G:C base pair is also the strongest determinant in G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14 which leads to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S) (Lagrange et al., 1998).</text>
                    <arg n="0">G979A affected a splice consensus site at the end of exon 8, and G1488T in exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>This G:C base pair is also the strongest determinant in G979A affects a splice consensus site at the end of exon 8, and G1488T in exon 14 which leads to a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S) (Lagrange et al., 1998).</text>
                    <arg n="0">G979A affects a splice consensus site at the end of exon 8, and G1488T in exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>This G:C base pair is also the strongest determinant in The splice mutation in 5 end of intron 5 leading to abnormal splice in exon 5 and exon 6 (Lagrange et al., 1998).</text>
                    <arg n="0">The splice mutation in 5 end of intron 5</arg>
                    <arg n="1">abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>This G:C base pair is also the strongest determinant in The splice mutation in 5 end of intron 5 leading to abnormal splice in exon 5 and exon 6 (Lagrange et al., 1998).</text>
                    <arg n="0">The splice mutation in 5 end of intron 5</arg>
                    <arg n="1">abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>This G:C base pair is also the strongest determinant in This splice mutation in 5 end of intron 5 which has led to abnormal splice in exon 5 and exon 6 (Lagrange et al., 1998).</text>
                    <arg n="0">This splice mutation in 5 end of intron 5</arg>
                    <arg n="1">abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>This G:C base pair is also the strongest determinant in This splice mutation in 5 end of intron 5 which leads to abnormal splice in exon 5 and exon 6 (Lagrange et al., 1998).</text>
                    <arg n="0">This splice mutation in 5 end of intron 5</arg>
                    <arg n="1">abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>This G:C base pair is also the strongest determinant in a complex splice site mutation which led to an abnormal JAG1 mRNA, resulting in a premature stop codon (Lagrange et al., 1998).</text>
                    <arg n="0">a complex splice site mutation</arg>
                    <arg n="1">an abnormal JAG1 mRNA, resulting in a premature stop codon</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>This G:C base pair is also the strongest determinant in a point mutation at the 5 splicing site of the third intron which leads to ligation of the second to the fourth exon (Lagrange et al., 1998).</text>
                    <arg n="0">a point mutation at the 5 splicing site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>This G:C base pair is also the strongest determinant in inactivation of the MEF2C gene, which led to cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5 (Lagrange et al., 1998).</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>This G:C base pair is also the strongest determinant in two frameshifts and a splice site mutation that leads to truncated OA1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (Lagrange et al., 1998).</text>
                    <arg n="0">two frameshifts and a splice site mutation</arg>
                    <arg n="1">truncated OA1 proteins; a deletion of a threonine codon at position 290; and four missense mutations</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>This splice mutation in 5 end of intron 5 can lead to abnormal splice in exon 5 and exon 6, an atypical form of Tay-Sachs disease (GM2 gangliosidosis variant AB).</text>
                    <arg n="0">This splice mutation in 5 end of intron 5</arg>
                    <arg n="1">abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>This splice mutation in 5 end of intron 5 was caused by This leading to abnormal splice in exon 5 and exon 6.</text>
                    <arg n="0">This splice mutation in 5 end of intron 5</arg>
                    <arg n="1">abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>This splice mutation in 5 end of intron 5, in turn, led to abnormal splice in exon 5 and exon 6 independently of the DNA-binding activity of MEF2.</text>
                    <arg n="0">This splice mutation in 5 end of intron 5</arg>
                    <arg n="1">abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>This was caused by This splice mutation in 5 end of intron 5 which can lead to abnormal splice in exon 5 and exon 6.</text>
                    <arg n="0">This splice mutation in 5 end of intron 5</arg>
                    <arg n="1">abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>This was caused by a complex splice site mutation which can lead to an abnormal JAG1 mRNA, resulting in a premature stop codon.</text>
                    <arg n="0">a complex splice site mutation</arg>
                    <arg n="1">an abnormal JAG1 mRNA, resulting in a premature stop codon</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele G:C base pair is also the strongest determinant in This leading to a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein (Lagrange et al., 1998).</text>
                    <arg n="0">a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele</arg>
                    <arg n="1">a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele can lead to a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein, an atypical form of Tay-Sachs disease (GM2 gangliosidosis variant AB).</text>
                    <arg n="0">a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele</arg>
                    <arg n="1">a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele has led to a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein (Figure 3A).</text>
                    <arg n="0">a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele</arg>
                    <arg n="1">a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele has led us to a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein.</text>
                    <arg n="0">a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele</arg>
                    <arg n="1">a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele was caused by This, which leads to a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein.</text>
                    <arg n="0">a C----A transversion in the splice acceptor sequence of the last intron of the only ERCC-3 allele</arg>
                    <arg n="1">a 4 bp insertion in the mRNA and an inactivating frameshift in the C-terminus of the protein</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>a complex splice site mutation G:C base pair is also the strongest determinant in This which leads to an abnormal JAG1 mRNA, resulting in a premature stop codon (Lagrange et al., 1998).</text>
                    <arg n="0">a complex splice site mutation</arg>
                    <arg n="1">an abnormal JAG1 mRNA, resulting in a premature stop codon</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>a complex splice site mutation has led to an abnormal JAG1 mRNA, resulting in a premature stop codon, an atypical form of Tay-Sachs disease (GM2 gangliosidosis variant AB).</text>
                    <arg n="0">a complex splice site mutation</arg>
                    <arg n="1">an abnormal JAG1 mRNA, resulting in a premature stop codon</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>a complex splice site mutation, but not a wild-type strain, led to an abnormal JAG1 mRNA, resulting in a premature stop codon.</text>
                    <arg n="0">a complex splice site mutation</arg>
                    <arg n="1">an abnormal JAG1 mRNA, resulting in a premature stop codon</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>a complex splice site mutation, in turn, leads to an abnormal JAG1 mRNA, resulting in a premature stop codon independently of the DNA-binding activity of MEF2.</text>
                    <arg n="0">a complex splice site mutation</arg>
                    <arg n="1">an abnormal JAG1 mRNA, resulting in a premature stop codon</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>a point mutation at the 5 splicing site of the third intron G:C base pair is also the strongest determinant in This that leads to ligation of the second to the fourth exon (Lagrange et al., 1998).</text>
                    <arg n="0">a point mutation at the 5 splicing site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>a point mutation at the 5 splicing site of the third intron has led to ligation of the second to the fourth exon.</text>
                    <arg n="0">a point mutation at the 5 splicing site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>a point mutation at the 5 splicing site of the third intron will lead us to ligation of the second to the fourth exon.</text>
                    <arg n="0">a point mutation at the 5 splicing site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>a point mutation at the 5 splicing site of the third intron will lead us to ligation of the second to the fourth exon.</text>
                    <arg n="0">a point mutation at the 5 splicing site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>a point mutation at the 5 splicing site of the third intron, in turn, has led to ligation of the second to the fourth exon independently of the DNA-binding activity of MEF2.</text>
                    <arg n="0">a point mutation at the 5 splicing site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>abnormal splice in exon 5 and exon 6 is led to by The splice mutation in 5 end of intron 5.</text>
                    <arg n="0">The splice mutation in 5 end of intron 5</arg>
                    <arg n="1">abnormal splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>inactivation of the MEF2C gene G:C base pair is also the strongest determinant in This that leads to cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5 (Lagrange et al., 1998).</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>inactivation of the MEF2C gene is able to lead to cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5 (Figure 3A).</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>inactivation of the MEF2C gene lead to cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">cardiac morphogenetic defects, vascular abnormalities and lethality by embryonic day 9.5</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>the distinct amino termini G:C base pair is also the strongest determinant in This which has led to the targeting of individual VDAC isoforms to different cellular compartments (Lagrange et al., 1998).</text>
                    <arg n="0">the distinct amino termini</arg>
                    <arg n="1">the targeting of individual VDAC isoforms to different cellular compartments</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>the distinct amino termini G:C base pair is also the strongest determinant in This which has led to the targeting of individual VDAC isoforms to different cellular compartments (Lagrange et al., 1998).</text>
                    <arg n="0">the distinct amino termini</arg>
                    <arg n="1">the targeting of individual VDAC isoforms to different cellular compartments</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>the distinct amino termini can lead to the targeting of individual VDAC isoforms to different cellular compartments (Figure 3A).</text>
                    <arg n="0">the distinct amino termini</arg>
                    <arg n="1">the targeting of individual VDAC isoforms to different cellular compartments</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>the targeting of individual VDAC isoforms to different cellular compartments is led to by the distinct amino termini.</text>
                    <arg n="0">the distinct amino termini</arg>
                    <arg n="1">the targeting of individual VDAC isoforms to different cellular compartments</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>two frameshifts and a splice site mutation G:C base pair is also the strongest determinant in This leading to truncated OA1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (Lagrange et al., 1998).</text>
                    <arg n="0">two frameshifts and a splice site mutation</arg>
                    <arg n="1">truncated OA1 proteins; a deletion of a threonine codon at position 290; and four missense mutations</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>two frameshifts and a splice site mutation may lead to truncated OA1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (Figure 3A).</text>
                    <arg n="0">two frameshifts and a splice site mutation</arg>
                    <arg n="1">truncated OA1 proteins; a deletion of a threonine codon at position 290; and four missense mutations</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>two frameshifts and a splice site mutation may lead to truncated OA1 proteins; a deletion of a threonine codon at position 290; and four missense mutations.</text>
                    <arg n="0">two frameshifts and a splice site mutation</arg>
                    <arg n="1">truncated OA1 proteins; a deletion of a threonine codon at position 290; and four missense mutations</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
